# A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-probabilistic-cost-effectiveness-analysis-of-venetoclax-and-obinutuzumab-as-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anuja Chatterjee,Gijs van de Wetering,Ron Goeree,Carolyn Owen,Anne Marie Desbois,Stéphane Barakat,Beenish S. Manzoor,Kavita Sail |
| Citations | 12 |
| DOI | 10.1007/s41669-022-00375-x |
| Fields | Immunology and Microbiology,Medicine,Social Sciences |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s41669-022-00375-x.pdf |
| OpenAlex ID | https://openalex.org/W4308254443 |
| PMID | 36334238 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Stéphane Barakat](https://scholariq.org/researchers/stephane-barakat/)

## Paper journal

- [PharmacoEconomics - Open](https://scholariq.org/journals/pharmacoeconomics-open/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.